Jenburkt Pharmaceuticals Ltd
BSE:524731

Watchlist Manager
Jenburkt Pharmaceuticals Ltd Logo
Jenburkt Pharmaceuticals Ltd
BSE:524731
Watchlist
Price: 1 088 INR -1.25%
Market Cap: 4.8B INR

Profitability Summary

Jenburkt Pharmaceuticals Ltd's profitability score is 62/100. We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

62/100
Profitability
Score

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

62/100
Profitability
Score
62/100
Profitability
Score

Margins

Earnings Waterfall
Jenburkt Pharmaceuticals Ltd

Margins Comparison
Jenburkt Pharmaceuticals Ltd Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
IN
Jenburkt Pharmaceuticals Ltd
BSE:524731
4.9B INR
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
982.2B USD
Loading...
Loading...
Loading...
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
526.1B USD
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
276.2B CHF
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
215.4B GBP
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
221.7B CHF
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
270.7B USD
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
145.8B USD
Loading...
Loading...
Loading...
No Stocks Found

Return on Capital

Return on Capital Comparison
Jenburkt Pharmaceuticals Ltd Competitors

Country Company Market Cap ROE ROA ROCE ROIC
IN
Jenburkt Pharmaceuticals Ltd
BSE:524731
4.9B INR
Loading...
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
982.2B USD
Loading...
Loading...
Loading...
Loading...
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
Loading...
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
526.1B USD
Loading...
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
276.2B CHF
Loading...
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
215.4B GBP
Loading...
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
221.7B CHF
Loading...
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
270.7B USD
Loading...
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK
Loading...
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
145.8B USD
Loading...
Loading...
Loading...
Loading...
No Stocks Found

Free Cash Flow

Free Cash Flow Analysis
Jenburkt Pharmaceuticals Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate